Diabetic cardiomyopathy.
Miocardiopatía diabética.
Diabetes
Diabetic cardiomyopathy
Heart failure
Insuficiencia cardiaca
Miocardiopatía diabética
Journal
Revista clinica espanola
ISSN: 1578-1860
Titre abrégé: Rev Clin Esp
Pays: Spain
ID NLM: 8608576
Informations de publication
Date de publication:
24 Feb 2020
24 Feb 2020
Historique:
received:
03
10
2019
revised:
13
10
2019
accepted:
21
10
2019
pubmed:
29
2
2020
medline:
29
2
2020
entrez:
29
2
2020
Statut:
aheadofprint
Résumé
The relationship between diabetes and heart failure is complex and bidirectional. Nevertheless, the existence of a cardiomyopathy attributable exclusively to diabetes has been and is still the subject of controversy, due, among other reasons, to a lack of a consensus definition. There is also no unanimous agreement in terms of the physiopathogenic findings that need to be present in the definition of diabetic cardiomyopathy or on its classification, which, added to the lack of diagnostic methods and treatments specific for this disease, limits its general understanding. Studies conducted on diabetic cardiomyopathy, however, suggest a unique physiopathogenesis different from that of other diseases. Similarly, new treatments have been shown to play a potential role in this disease. The following review provides an update on diabetic cardiomyopathy.
Identifiants
pubmed: 32107015
pii: S0014-2565(20)30025-4
doi: 10.1016/j.rce.2019.10.013
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
spa
Informations de copyright
Copyright © 2020 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.